MTEX in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with MTEX today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Mannatech sells proprietary nutritional supplements, skin-care and anti-aging products, and weight-management and fitness products. Independent associates and preferred customers buy at discounted prices for personal use or, in associates’ case, resale to consumers. Associates also recruit other associates and earn commissions on qualifying sales made by themselves and their networks. Preferred customers get the same pricing but do not participate in the compensation plan. Product purchases generate nearly all revenue, rather than associate fees or training services.
The business depends heavily on keeping associates active and productive. Ambrotose Life, TruHealth, Optimal Support Packets and Ambrotose products supply a significant part of revenue, and South Korea is its largest market. Third-party manufacturers make all its products; Mannatech currently has no identified alternative supplier for Arabinogalactan, an important ingredient in Ambrotose formulations.
Mainland China follows a different model. Consumers buy overseas-made products through subsidiary Meitai’s website for personal use, not resale. Meitai cannot operate multi-level marketing there, and customs rules limit purchases to personal-consumption quantities. It encourages customer referrals through a rewards program.
Mannatech needs higher product sales or lower costs to fund operations and has identified substantial doubt about its ability to continue operating.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
USANA competes with Mannatech for both buyers of proprietary nutritional supplements and independent sellers who buy for personal use or resale. Watch USANA’s core nutritional active Customers—buyers in the latest three months—for changes in the customer and seller pool Mannatech also needs.
Nature’s Sunshine competes with Mannatech for supplement buyers and independent sellers; both sell nutritional and personal-care products to people who use them or resell them to consumers. Successful consultant recruitment and retention at Nature’s Sunshine can leave fewer independent sellers available to Mannatech.
Herbalife competes with Mannatech for wellness customers, selling nutrition, weight-management and fitness products through independent networks to buyers who use them or resell them. Its weight-management sales, including meal replacements and protein shakes, offer a read on the spending Mannatech’s weight and fitness products compete for.
Nu Skin competes with Mannatech for independent sellers and buyers of wellness and skin-care products, which both sell through person-to-person networks. Watch Nu Skin’s beauty and wellness sales rather than revenue from Rhyz’s outside customers when assessing demand relevant to Mannatech.
USANA Health Sciences Inc earningsUSNA
USANA’s active-customer count in its core nutrition business shows whether it is drawing buyers who may also consider Mannatech’s supplements.
Look at the number of active Customers in USANA’s core nutrition business over the latest three months. A rise means this rival is attracting or keeping more supplement buyers, potentially intensifying Mannatech’s competition for the same customers, but it does not show that Mannatech has lost them. A decline may ease that pressure, or signal weaker demand; it is not proof that Mannatech is gaining ground.